IP Library Granted Patent US 10,167,193
Granted Patent B2
US 10,167,193 · App. 14/863,388 · Granted Jan 1, 2019

Ferroelectric agglomerates and methods and uses related thereto

Inventors: Sandra J. Rosenthal (Nashville, TN); Toshia Wrenn (La Vergne, TN)
Assignee: Vanderbilt University
B82Y30/00C01B19/007H01L41/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,167,193
App. No.
14/863,388
Granted
Jan 1, 2019
Kind
B2
Abstract

Disclosed herein are ferroelectric agglomerates and methods related thereto. In certain aspects, the ferroelectric agglomerates can be made from particles that have been treated with SbX 3 or SbX 5 , wherein X is a halogen. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claims (31)

1. An agglomerate comprising:

(a) a particle having a body, wherein the body comprises antimony and a first atom;

(b) a matrix comprising a halogen and a second atom; and

(c) a surface ligand bound to the particle,

wherein the particle is at least partially embedded in the matrix,

wherein the first atom and the second atom are independently selected from Cd, Se, Pb, S, Fe, O, Au, Ag, Te, In, Sn, Eu, Ti, and Ba; and

wherein the agglomerate is ferroelectric.

2. The agglomerate of claim 1 , wherein the halogen is Cl or I.

3. The agglomerate of claim 1 , wherein the body further comprises CdSe, PbS, Fe 3 O 2 , Au, CdTe—CdS, Ag, ZnO, Au, AgInS 2 —ZnS, ZnCuInS—ZnS, SnS, EuS, or CdSe—ZnS, or a combination thereof.

4. The agglomerate of claim 1 , wherein the first atom is Se.

5. The agglomerate of claim 1 , wherein the second atom is Cd.

6. The agglomerate of claim 1 , wherein the surface ligand is selected from (R 1 ) m -alkyl, (R 1 ) m -alkenyl, (R 1 ) m -alkynyl, and (R 1 ) m -peptide, and is substituted with 0, 1, 2, or 3 groups selected from aryl, cycloalkyl, cycloalkenyl, heterocyclyl, heteroaryl, -alkyl-aryl, -alkenyl-aryl, alkynyl-aryl, -alkyl-cycloalkyl, -alkenyl-cycloalkyl, alkynyl-cycloalkyl, alkyl-heterocyclyl, -alkenyl-heterocyclyl, alkynyl-heterocyclyl, -alkyl-heteroaryl, -alkenyl-heteroaryl, alkynyl-heteroaryl, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, alkoxy, aryloxy, mono- or di-alkylamino, a mono- or diaryl amino, hydroxyl, thiol, nitro, cyano, amino, halo, —C(O)O—R 2 , —C(O)—R 2 , —COR 2 , and —OR 2 ;

wherein each R 1 is independently selected from —COOH, —NH 2 , —SH, —Si(R 3 ) 3 , and —PO(OR 4 ) 2 ;

wherein each R 2 is independently selected from hydrogen, alkyl, haloalkyl, polyhaloalkyl, alkylamino, dialkylamino, -alkyl-aryl, and -alkyl-heterocyclyl;

wherein each R 3 is independently selected from hydrogen, halogen, and alkyl;

wherein each R 4 is independently selected from hydrogen, alkyl, and aryl; and

wherein m is 1, 2, 3, 4, or 5.

7. The agglomerate of claim 1 , wherein the surface ligand is selected from oleic acid, oleylamine, citrate, cysteamine, glutathione, and mercaptoundecanoic acid.

8. The agglomerate of claim 1 , wherein the agglomerate has a diameter from 4 nm to 50 μm.

9. The agglomerate of claim 1 , wherein the agglomerate comprises two or more particles.

10. The agglomerate of claim 1 , wherein the particle is a nanoparticle.

11. The agglomerate of claim 1 , wherein the particle is fluorescent or radioactive.

12. The agglomerate of claim 1 , wherein the first atom is an anion.

13. The agglomerate of claim 1 , wherein the second atom is a cation.

14. The agglomerate of claim 1 , wherein the first atom and the second atom are the same type of atom.

15. The agglomerate of claim 1 , wherein the first atom is Se, and wherein the first atom and antimony together form Sb 2 Se 3 .

16. The agglomerate of claim 1 , wherein the body further comprises CdSe.

17. The agglomerate of claim 1 , wherein the matrix is a semi-crystalline matrix.

18. The agglomerate of claim 1 , wherein the halogen is Cl, wherein the second atom is Cd, and wherein the halogen and the second atom together form CdCl 2 .

19. The agglomerate of claim 1 , wherein the surface ligand is an organic surface ligand.

20. The agglomerate of claim 1 , wherein the particle is a nanoparticle, wherein the first atom is Se, wherein the body further comprises CdSe, wherein the second atom is Cd, wherein the surface ligand is an organic surface ligand, wherein the matrix is semi-crystalline, and wherein the halogen is Cl.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 27, 2019
From: VANDERBILT UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 050580/0074 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2016
From: ROSENTHAL, SANDRA J.; WRENN, TOSHIA
To: VANDERBILT UNIVERSITY
Reel/Frame 038599/0176 →
Continuity (2)
Provisional Application 62054306 · Sep 23, 2014
Related Publication 20160087191A1 · Mar 24, 2016